MedTrace Logo

Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring

NCT01072565 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2015-11-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of Self Monitoring of Blood Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to determine the benefit of using Continuous Glucose Monitoring (CGM) for clinical diabetes management.

Conditions

Interventions

OTHER

SMBG to guide clinical decisions

The investigator will base clinical decisions on A1c and modal day analysis of SMBG.

OTHER

SMBG and CGM

The investigator will base clinical decisions on A1c, modal day analysis of SMBG and CGM data.

Sponsors & Collaborators

  • International Diabetes Center at Park Nicollet

    collaborator OTHER

  • Abbott Diabetes Care

    collaborator INDUSTRY

  • HealthPartners Institute

    lead OTHER

Principal Investigators

  • Roger S Mazze, PhD · International Diabetes Center at Park Nicollet

  • Elinor S Strock, APRN, BC · International Diabetes Center at Park Nicollet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01072565 on ClinicalTrials.gov